With a projected 7% dividend yield, is the Medibank share price a buy?

Investors may receive very healthy dividends from this stock.

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

According to projections, Medibank Private Ltd (ASX: MPL) investors are likely to enjoy a good dividend yield in the next 12 months based on the current Medibank share price of $3.79.

Medibank is the largest private health insurer in Australia through its two brands, Medibank and Ahm. This approach allows it to offer both full-service and discounted private health insurance to Australians.

I think it's worthy of attention from passive income investors for two key reasons – the dividend and the growing earnings.

Let's explore why this ASX dividend share could be appealing, starting with the payout.

Large and growing dividend with Medibank shares

Quite a few ASX companies pay large dividends, and some have a record for hiking their shareholder payments year after year. Medibank can provide a mix of those two elements, which is something I like.

The ASX healthcare share has been listed on the ASX for just over a decade. Aside from the COVID-hit 2020 year, Medibank has grown its dividend payout every year since 2015. That's a solid record, in my view.

According to the projection on Commsec, it could pay an annual dividend per share of 18.5 cents. At the current Medibank share price, that would be a fully franked dividend yield of 4.9% and a grossed-up dividend yield of 7%, including franking credits. That's a solid near-term yield, in my view. More dividend growth is expected in FY25.

Rising earnings

Rising earnings are a key factor in a good ASX dividend share, in my view. Growing profit helps fund the current dividend and can drive the dividend higher.

In the FY24 result, Medibank reported a 14.1% rise in underlying earnings per share (EPS) to 20.7 cents, and this helped the dividend per share grow to 16.6 cents.

The forecast on Commsec suggests EPS could rise to 23 cents, which would mean profit going in the right direction.

In its FY24 results, Medibank advised that it expected slower industry growth in FY25 compared to FY24.

In terms of Australian resident health insurance customer growth, the company said it would remain "disciplined" as it aimed to grow in line with the market in FY25, including volume growth with the Medibank brand. It will target market share growth in FY26.

However, regarding non-resident health insurance, it expects "solid" policy unit growth to continue in FY25. This grew by 25.1%, or 69,000, in FY24.

The company is targeting $10 million of productivity savings in FY25 and expects claims per policy unit growth of around 2.7%.

Overall, it looks positive that the business could grow both earnings and dividends in FY25. That may also be good news for the Medibank share price this year.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A businesswoman exhales a deep sigh after receiving bad news, and gets on with it.
Earnings Results

Cochlear share price sinks 10% on half-year result disappointment

Let's see why investors are hitting the sell button this morning.

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

The CSL share price hit a 52-week low this week. Is it time to buy?

Is this beaten-up biotech a healthy opportunity?

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Sigma share price up 9% on first day of trading post-merger with Chemist Warehouse

It's a post-merger party for Sigma Healthcare shareholders today.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock.

Read more »

Stethoscope with a piggy bank in the middle.
Healthcare Shares

With revenue up 9%, why does the NIB share price keep falling?

Will the ailing share price make a full recovery?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Guess how much $5,000 invested in Sigma shares in December 2023 is worth now!

Sigma shares have soared over the past year alongside the merger with Chemist Warehouse.

Read more »

Woman with headphones on relaxing and looking at her phone happily.
Healthcare Shares

Everything you need to know about the latest CSL dividend

CSL's latest dividend should be turning investors' heads...

Read more »

thoughtful investor sitting at computer
Healthcare Shares

What are brokers saying about CSL shares after the selloff?

The biotech giant's shares hit a 52-week low yesterday. Is this a buying opportunity?

Read more »